Events
Past Events
January 10, 2024 at 3:00 PM PST
November 28, 2023 at 1:30 PM EST
September 27, 2023 at 8:35 AM EDT
September 13, 2023 at 12:30 PM EDT
March 7, 2023 at 9:10 AM EST
February 14, 2023 at 10:00 AM EST
January 9 - January 12, 2023
November 29, 2022 at 4:30 PM EST
August 9, 2022 at 8:00 AM EDT
March 8, 2022 at 12:50 PM EST
February 17, 2022 at 1:30 PM EST
February 17, 2022 at 12:00 PM EST
January 11, 2022 at 11:15 AM EST
November 10, 2021 at 4:30 PM EST
September 27, 2021 at 2:40 PM EDT
September 13, 2021 at 7:00 AM EDT
September 9 - September 15, 2021
September 9 - September 10, 2021
September 7, 2021
August 12, 2021 at 8:00 AM EDT
August 10, 2021 at 2:20 PM EDT
July 14, 2021 at 2:10 PM EDT
June 14, 2021 at 8:30 AM EDT
June 2, 2021 at 8:00 AM EDT
May 13, 2021 at 4:30 PM EDT
April 12, 2021 at 8:00 AM EDT
March 9, 2021 at 7:00 AM EST
March 2, 2021 at 11:50 AM EST
February 24, 2021 at 3:00 PM EST
January 12, 2021 at 9:10 AM EST
December 1 - December 3, 2020
November 19, 2020
November 17 - November 19, 2020
November 12, 2020 at 12:30 PM EST
September 15, 2020 at 5:00 PM EDT
September 9 - September 10, 2020
For investors
Discover more about iTeos Therapeutics, our science, and our high potential for investment.
At iTeos we are pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics.
Our differentiated development approach is driven by biologic rationale and clinical need utilizing our IO candidates in intra-portfolio combinations and with programs of external collaborators.
Driven by a culture of scientific innovation, collaboration and excellence, together we discover and deliver breakthrough immunotherapies to improve and extend the lives of people with cancer.